Celon Pharma
CLN.WA
$8.49
Share price
-0.62%
Change (1 day)
67.02%
Change (1 year)
Categories
EPS for Celon Pharma (CLN.WA)
EPS in 2024 (TTM): -$0.14
According to Celon Pharma's latest financial reports the company's current EPS (TTM) is -$0.14. In 2023 the company made an earnings per share (EPS) of -$0.18 an increase over its 2022 EPS that were of -$0.23.
EPS history for Celon Pharma from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$0.14 | -21.23% |
| 2023 | -$0.18 | -20.64% |
| 2022 | -$0.23 | 186.32% |
| 2021 | -$0.08090 | 1047.74% |
| 2020 | -$0.007049 | -107.56% |
| 2019 | $0.09329 | -59.53% |
| 2018 | $0.23 | 7.36% |
| 2017 | $0.21 | -18.58% |
| 2016 | $0.26 | -5.31% |
| 2015 | $0.28 |